ArticleTrials2020

Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study.

Frank Tegtmeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.